About
AI for adverse event prediction
Areas of Focus
Categories
AI FocusedBoston & New England
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
1
As Collaborator
4
Total Enrollment
1,722
By Phase
NA: 2
By Status
UNKNOWN: 4ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
2025
Today
Hover over trial bars to see details
Recent Trials
NCT04849312Collaborator
Prediction of 30-Day Readmission Using Machine Learning
N/AUnknown
500 participants
Started: Mar 20, 2022 · Completed: Dec 1, 2022
NCT04784351Collaborator
Prediction of Expected Length of Hospital Stay Using Machine Learning
N/AUnknown
500 participants
Started: Mar 20, 2021 · Completed: Dec 1, 2021
NCT05045742Collaborator
Prediction of Patient Deterioration Using Machine Learning
N/AUnknown
500 participants
Started: Mar 20, 2021 · Completed: Dec 1, 2021
NCT04191330Lead Sponsor
Artificial Intelligence Mobile Health Trial Of A Digital Platform To Optimize GDMT Using Wearable Sensors
NAActive, not recruiting
122 participants
Started: Jan 27, 2020 · Completed: Aug 31, 2024
NCT03415841Collaborator
Kardia - A Smartphone-based Care Model for Outpatient Cardiac Rehabilitation
NAUnknown
100 participants
Started: Feb 1, 2018 · Completed: Mar 31, 2020
Locations (1)
Headquarters
Needham, MA, United States
Map
Loading map...